RE:RE:RE:RE:RE:This board is now complete trash talk !2b7f6fab wrote: TLT should be putting out a quarterly update by month end. I don't understand all the complaining about mgmt on this board. The study is being conducted by the hospitals and not mgmt. It is mgmt that has performed to get TLT into PH2 trials. That's quite an accomplishment if you ask me. Sure things have taken longer than any of us thought. Again that was due to covid, and bureaucratic foot dragging on study 1 approval, TLT would be $3 to $5 stock now if PH2 trial was performed with correct dosing from the start.
Day in and day out I read the constant belly aching on this board about mgmt but I don't see that these delays were mgmt fault.
But made wrong decision to dilute at dirty low levels (after great milestone achievement news) and care only about their own trough by issuing too many free option to themselves without caring long shareholders' value, and made fake promise of seeing J. V ("in the immediate future") yet never carried out for over 3 years, absolute their fault.